glp 1 agonists in development GLP-1R for Weight Loss Emerging Trends in the Development

from GLP-1 Trends: Lifestyle Changes, Dining Habits, and Mental Health

This article thoroughly traces the developmental milestones of GLP-1 drugs, from their initial discovery to their clinical application, detailing the evolution of diverse GLP-1 medications along with their distinct pharmacological properties

Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are highly effective for glycaemic control and weight loss in patients with type 2 diabetes (T2D)

In clinical trials, it led to a weight reduction of up to 16.2%

The findings suggest AI could turn social media into a powerful early-warning system for spotting side effects that clinical trials may miss.